The Early Treatment for Retinopathy of Prematurity Clinical Trial: Presentation by subgroups versus analysis within subgroups

British Journal of Ophthalmology

Volumn 90, Issue 11, 2006, Pages 1341-1342

  Hardy, R J ^a   Good, W V ^b   Dobson, V ^c   Palmer, E A ^d   Tung, B ^a   Phelps, D L ^e   Shapiro, M J ^f   Van Heuven, W A J ^g  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b SMITH KETTLEWELL EYE RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; CLINICAL PRACTICE; CLINICAL TRIAL; DISEASE CLASSIFICATION; HIGH RISK POPULATION; HUMAN; MEDICAL DECISION MAKING; NOTE; PRIORITY JOURNAL; RETINA DETACHMENT; RETROLENTAL FIBROPLASIA; TREATMENT OUTCOME;

DATA INTERPRETATION, STATISTICAL; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LASER SURGERY; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RETINOPATHY OF PREMATURITY; RISK FACTORS; TREATMENT OUTCOME;

EID: 33750726739     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2006.102038     Document Type: Note

References (12)

1. The Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol 2003;121:1684-96.
2. Good WV. The Early Treatment for Retinopathy of Prematurity Study: Structural findings at age 2 years. Br J Ophthalmol 2006;90:1378-82.
3. The Early Treatment for Retinopathy of Prematurity Cooperative Group. Multicenter trial of early treatment for retinopatny of prematurity: study design. Control Clin Trials 2004;25:311-25.
4. Hardy RJ, Palmer EA, Dobson V, et al. On behalf of CRYO-ROP Cooperative Group. Risk analysis of prethreshold ROP. Arch Ophthalmol 2003;121:1697-701.
5. Good WV, Hardy RJ. The dilemma of exercising clinical judgment in the treatment of retinopathy of prematurity-reply. Arch Ophthalmol 2005;123:409-10.
6. Averbukh E. The evidence supporting the early treatment for type 1 retinopathy of prematurity needs further evaluation. Arch Ophthalmol 2005;123:406.
7. Vander JF, McNamara JA, Tasman W, et al. Revised indications for early treatment of retinopathy of prematurity. Arch Ophthalmol 2005;123:406-7.
8. Jalali S, Essuman V, Thomas R. Clinical application of the revised indications for the treatment of retinopathy of prematurity. Arch Ophthalmol 2005;123:407-8.
9. Early Treatment for Retinopathy of Prematurity Cooperative Group. Manual of procedures. Springfield, VA: National Technical Information Service, 2004.
10. The STOP-ROP Multicenter Study Group. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes, Pediatrics 2000;105:295-310.
11. Peto R, Collins R, Gray R. Large-scale randomized evidence: large, simple trials and overviews of trials. ICRF/MRC/BHF Clinical Trial Service Unit, University of Oxford, Oxford, UK. J Clin Epidemiol 1995;48:23-40.
12. Yusuf S, Wittes J, Probstfield J, et al. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA 1991;266:93-8.